Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.3 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.61.
Market Cap
9.3T
Revenue
4.66T
Profits
187.49B
PE Ratio
49.61
Profit Margin
4.02%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 0.31% | 518,978 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 629.80B | 0.18% | 1,140,785 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 443.72B | 0.94% | 1,610,874 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 361.78B | -0.62% | 897,891 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 332.33B | 1.34% | 1,749,337 | 66.57B |
| 6 | NVS | Novartis AG | 290.81B | 0.16% | 456,456 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.13B | -0.19% | 1,054,715 | 61.37B |
| 8 | AMGN | Amgen Inc. | 225.91B | 0.41% | 272,003 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 222.26B | -0.32% | 381,776 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 204.47B | -0.97% | 4,301,322 | 50.34B |
| 11 | ABT | Abbott Laboratories | 192.56B | 0.33% | 1,827,397 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 170.28B | 1.07% | 1,080,376 | 30.46B |
| 13 | PFE | Pfizer Inc. | 152.64B | 1.79% | 10,267,856 | 63.70B |
| 14 | DHR | Danaher Corporation | 143.64B | -0.71% | 465,187 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.11B | -0.46% | 616,874 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.00B | -0.19% | 176,192 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 131.73B | 1.24% | 2,373,163 | 49.19B |
| 18 | SYK | Stryker Corporation | 130.97B | -1.66% | 411,268 | 25.84B |
| 19 | CVS | CVS Health Corporation | 121.95B | 0.67% | 1,552,817 | 412.65B |
| 20 | MDT | Medtronic plc | 116.52B | 0.30% | 1,412,241 | 36.36B |
| 21 | SNY | Sanofi | 104.29B | 0.67% | 566,983 | 55.89B |
| 22 | GSK | GSK plc | 101.15B | 0.14% | 808,565 | 44.05B |
| 23 | MCK | McKesson Corporation | 100.18B | -2.22% | 258,439 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 88.24B | -1.69% | 344,459 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.90B | 0.39% | 178,565 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.63B | 1.19% | 125,647 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.77B | 0.33% | 4,761,549 | 21.00B |
| 28 | CI | The Cigna Group | 73.51B | 0.28% | 186,557 | 282.38B |
| 29 | COR | Cencora, Inc. | 59.69B | -0.43% | 490,510 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.74B | 0.17% | 679,918 | 28.42B |
| 31 | ARGX | argenx SE | 54.93B | -0.42% | 32,189 | 5.32B |
| 32 | CAH | Cardinal Health, Inc. | 53.88B | -1.06% | 507,688 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 53.88B | 0.46% | 325,782 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 50.08B | 0.15% | 342,917 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.61B | -0.14% | 1,677,402 | 29.94B |
| 36 | HUM | Humana Inc. | 46.12B | -1.21% | 172,783 | 145.68B |
| 37 | NTRA | Natera, Inc. | 45.02B | -1.16% | 227,739 | 2.71B |
| 38 | IDXX | IDEXX Laboratories, Inc. | 44.68B | -0.60% | 114,012 | 4.55B |
| 39 | RVMD | Revolution Medicines, Inc. | 43.81B | -0.41% | 179,232 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.86B | 0.11% | 2,414,517 | 17.32B |
| 41 | HLN | Haleon plc | 42.82B | -0.41% | 1,788,355 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 41.98B | 0.28% | 271,937 | 7.23B |
| 43 | WAT | Waters Corporation | 40.96B | 0.17% | 185,128 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 40.66B | -0.40% | 105,298 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 39.66B | -0.31% | 160,910 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 38.97B | -0.66% | 609,851 | 3.32B |
| 47 | ALC | Alcon Inc. | 35.26B | -0.44% | 533,925 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 34.44B | 0.52% | 1,459,440 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.86B | -0.57% | 409,251 | 2.54B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 33.09B | 1.34% | 739,747 | 21.27B |
| 51 | CNC | Centene Corporation | 32.94B | -0.58% | 727,282 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.57B | -0.09% | 261,321 | 5.65B |
| 53 | BIIB | Biogen Inc. | 31.03B | 0.54% | 289,847 | 10.03B |
| 54 | ZTS | Zoetis Inc. | 30.58B | 0.64% | 1,623,003 | 9.53B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.25B | 0.94% | 347,011 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 28.88B | -0.87% | 272,182 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.60B | -0.77% | 19,740 | 4.13B |
| 58 | INSM | Insmed Incorporated | 27.88B | -3.48% | 436,809 | 1.14B |
| 59 | PHG | Koninklijke Philips N.V. | 26.16B | 1.36% | 340,015 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 26.13B | -0.40% | 64,271 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 26.13B | 0.03% | 1,407,287 | 7.53M |
| 62 | DGX | Quest Diagnostics Incorporated | 26.12B | -0.48% | 113,069 | 11.56B |
| 63 | MRNA | Moderna, Inc. | 25.81B | 1.52% | 1,738,997 | 2.23B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.56B | -0.92% | 87,459 | 3.33B |
| 65 | INCY | Incyte Corporation | 24.47B | -0.03% | 202,549 | 5.82B |
| 66 | BNTX | BioNTech SE | 23.37B | 0.32% | 126,776 | 3.03B |
| 67 | STE | STERIS plc | 22.94B | -0.58% | 86,169 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 21.77B | -0.82% | 76,839 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 21.73B | -1.93% | 255,007 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.39B | -0.45% | 342,041 | 21.81B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 18.80B | 0.66% | 577,002 | 8.51B |
| 72 | GMAB | Genmab A/S | 18.77B | -0.60% | 1,731,269 | 4.13B |
| 73 | VTRS | Viatris Inc. | 18.76B | 1.43% | 3,835,084 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.50B | -1.00% | 42,695 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.26B | -3.47% | 300,621 | 1.20B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.12B | -1.63% | 119,331 | 713.07M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.04B | -0.73% | 92,933 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.50B | -2.53% | 812,675 | 3.37B |
| 79 | COO | The Cooper Companies, Inc. | 15.00B | 0.25% | 350,280 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.63B | 0.76% | 161,637 | 8.31B |
| 81 | BAX | Baxter International Inc. | 13.95B | 0.15% | 1,398,733 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.62B | 0.30% | 192,611 | 4.00B |
| 83 | BMRN | BioMarin Pharmaceutical Inc. | 13.37B | -1.65% | 451,507 | 3.41B |
| 84 | RVTY | Revvity, Inc. | 13.05B | -0.76% | 150,114 | 2.91B |
| 85 | PEN | Penumbra, Inc. | 12.86B | -0.02% | 39,548 | 1.50B |
| 86 | ICLR | ICON Public Limited Company | 12.76B | -1.09% | 100,260 | 8.29B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.67B | 1.88% | 343,575 | 14.37B |
| 88 | EXEL | Exelixis, Inc. | 12.55B | 0.56% | 360,772 | 2.44B |
| 89 | FMS | Fresenius Medical Care AG | 12.54B | -0.44% | 118,217 | 22.19B |
| 90 | SNN | Smith & Nephew plc | 12.42B | 0.40% | 337,278 | 6.30B |
| 91 | ALGN | Align Technology, Inc. | 12.38B | 0.16% | 91,722 | 4.14B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.33B | 0.07% | 157,683 | 669.50M |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.20B | -1.52% | 32,699 | 1.28B |
| 94 | EHC | Encompass Health Corporation | 12.20B | -0.95% | 102,111 | 6.21B |
| 95 | CORT | Corcept Therapeutics Incorporated | 11.96B | -1.38% | 113,923 | 830.81M |
| 96 | SMMT | Summit Therapeutics Inc. | 11.81B | -1.99% | 906,913 | - |
| 97 | DVA | DaVita Inc. | 11.57B | -0.03% | 145,696 | 14.01B |
| 98 | AXSM | Axsome Therapeutics, Inc. | 11.53B | 2.58% | 184,564 | 776.57M |
| 99 | GMED | Globus Medical, Inc. | 11.45B | -0.48% | 307,153 | 3.14B |
| 100 | HALO | Halozyme Therapeutics, Inc. | 11.33B | -1.96% | 469,450 | 1.66B |
| 101 | ELAN | Elanco Animal Health Incorporated | 11.31B | 2.33% | 782,698 | 5.02B |
| 102 | TECH | Bio-Techne Corporation | 11.25B | -0.08% | 813,533 | 1.22B |
| 103 | GKOS | Glaukos Corporation | 11.02B | 0.17% | 127,092 | 612.84M |
| 104 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 10.87B | -1.42% | 226,867 | 5.67M |
| 105 | MOH | Molina Healthcare, Inc. | 10.74B | 0.04% | 97,175 | 42.47B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 10.67B | -1.06% | 64,901 | 7.46M |
| 107 | ENSG | The Ensign Group, Inc. | 10.52B | 0.27% | 43,377 | 5.49B |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 10.47B | 0.20% | 578,460 | 3.50B |
| 109 | CYTK | Cytokinetics, Incorporated | 10.45B | -0.59% | 454,898 | 67.67M |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.15B | -0.01% | 330,762 | - |
| 111 | UHS | Universal Health Services, Inc. | 10.05B | -1.12% | 254,282 | 18.11B |
| 112 | PODD | Insulet Corporation | 10.04B | -0.21% | 222,330 | 3.05B |
| 113 | HSIC | Henry Schein, Inc. | 10.03B | -0.78% | 169,503 | 13.60B |
| 114 | PTGX | Protagonist Therapeutics, Inc. | 9.93B | 0.94% | 75,619 | 281.99M |
| 115 | KRYS | Krystal Biotech, Inc. | 9.89B | 0.38% | 28,629 | 440.48M |
| 116 | TEM | Tempus AI, Inc. | 9.76B | -0.92% | 881,329 | 1.43B |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.66B | -0.18% | 24,364 | 2.59B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.51B | 0.34% | 80,409 | 105.00M |
| 119 | RGEN | Repligen Corporation | 9.38B | 0.29% | 149,856 | 785.10M |
| 120 | AVTR | Avantor, Inc. | 9.35B | -0.75% | 1,269,433 | 6.56B |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 9.31B | -0.88% | 164,582 | 874.09M |
| 122 | OSCR | Oscar Health, Inc. | 9.21B | 0.88% | 1,160,820 | 15.32B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.06B | -1.33% | 129,136 | - |
| 124 | QGEN | Qiagen N.V. | 8.99B | 1.08% | 871,503 | 2.10B |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.96B | 0.02% | 467,328 | 42.16M |
| 126 | BRKR | Bruker Corporation | 8.95B | -0.94% | 378,542 | 3.50B |
| 127 | PCVX | Vaxcyte, Inc. | 8.93B | 0.60% | 178,418 | - |
| 128 | HQY | HealthEquity, Inc. | 8.83B | 0.14% | 39,348 | 1.34B |
| 129 | IMVT | Immunovant, Inc. | 8.76B | -0.40% | 244,866 | - |
| 130 | ATR | AptarGroup, Inc. | 8.41B | -0.62% | 30,029 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.40B | -0.46% | 189,229 | 1.67B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.17B | 0.90% | 156,786 | 239.92M |
| 133 | IBRX | ImmunityBio, Inc. | 8.14B | -0.78% | 2,786,818 | 165.79M |
| 134 | TWST | Twist Bioscience Corporation | 7.81B | -0.53% | 191,161 | 431.80M |
| 135 | TXG | 10x Genomics, Inc. | 7.67B | 1.89% | 882,598 | 616.91M |
| 136 | PACS | PACS Group, Inc. | 7.32B | 1.69% | 66,067 | 5.55B |
| 137 | CHE | Chemed Corporation | 7.04B | -0.05% | 27,689 | 2.60B |
| 138 | HNGE | Hinge Health, Inc. | 7.03B | 0.90% | 170,118 | 720.06M |
| 139 | ORKA | Oruka Therapeutics, Inc. | 7.01B | -1.42% | 188,376 | - |
| 140 | GRFS | Grifols, S.A. | 6.96B | 0.25% | 59,164 | 8.48B |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.85B | -2.04% | 5,890,737 | 2.58B |
| 142 | TGTX | TG Therapeutics, Inc. | 6.84B | -2.55% | 422,795 | 799.54M |
| 143 | BLTE | Belite Bio, Inc | 6.76B | -3.91% | 116,791 | - |
| 144 | CGON | CG Oncology, Inc. | 6.74B | -1.22% | 217,414 | 6.23M |
| 145 | LQDA | Liquidia Corporation | 6.73B | -4.55% | 1,044,046 | 450.91M |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.66B | 1.67% | 176,849 | - |
| 147 | COGT | Cogent Biosciences, Inc. | 6.66B | -1.51% | 345,386 | - |
| 148 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.14% | 139,782 | 1.56B |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.47B | 0.68% | 89,498 | 618.07M |
| 150 | CAI | Caris Life Sciences, Inc. | 6.41B | 1.98% | 921,579 | 989.61M |
| 151 | ERAS | Erasca, Inc. | 6.38B | -1.83% | 372,926 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 6.24B | -1.19% | 125,557 | 7.50M |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.22B | -1.12% | 93,672 | 1.90M |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.14B | 0.75% | 92,708 | 840.85M |
| 155 | PTCT | PTC Therapeutics, Inc. | 6.06B | -0.11% | 143,451 | 1.01B |
| 156 | BLCO | Bausch + Lomb Corporation | 6.04B | 0.89% | 84,294 | 5.32B |
| 157 | RDNT | RadNet, Inc. | 6.02B | -0.53% | 172,647 | 2.27B |
| 158 | DFTX | Definium Therapeutics, Inc. | 5.91B | 2.83% | 857,502 | - |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.89B | 0.49% | 294,624 | 591.33M |
| 160 | STVN | Stevanato Group S.p.A. | 5.83B | 0.47% | 139,446 | 1.40B |
| 161 | TFX | Teleflex Incorporated | 5.80B | 0.45% | 105,536 | 2.25B |
| 162 | MMED | MiniMed Group, Inc. | 5.76B | -0.97% | 134,421 | 3.10B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -1.80% | 32,878 | 290.54M |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.68B | 0.79% | 434,322 | 3.12B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.45B | 0.05% | 112,608 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.41B | 0.42% | 243,874 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.19B | -0.50% | 232,546 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.01B | -1.32% | 214,249 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.90B | 0.23% | 734,588 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.73B | - | 188,605 | - |
| 171 | WAY | Waystar Holding Corp. | 4.70B | -0.16% | 264,360 | 1.21B |
| 172 | LFST | LifeStance Health Group, Inc. | 4.64B | -0.74% | 811,707 | 1.58B |
| 173 | MANE | Veradermics, Incorporated | 4.64B | 1.79% | 182,692 | - |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.63B | -2.86% | 39,268 | - |
| 175 | NVST | Envista Holdings Corporation | 4.58B | -0.64% | 273,295 | 2.86B |
| 176 | INDV | Indivior Pharmaceuticals, Inc. | 4.56B | -0.34% | 231,314 | 1.33B |
| 177 | BLLN | BillionToOne, Inc. | 4.53B | -1.48% | 170,256 | 397.41M |
| 178 | ICUI | ICU Medical, Inc. | 4.52B | 0.74% | 28,197 | 2.16B |
| 179 | LIVN | LivaNova PLC | 4.50B | 1.09% | 189,043 | 1.47B |
| 180 | DOCS | Doximity, Inc. | 4.49B | 0.88% | 944,265 | 655.57M |
| 181 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 1.27% | 349,191 | 2.29B |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.44B | 0.90% | 687,084 | 10.35M |
| 183 | CELC | Celcuity Inc. | 4.40B | -2.05% | 273,410 | - |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.35B | 0.82% | 337,590 | 53.81M |
| 185 | ITGR | Integer Holdings Corporation | 4.26B | 0.14% | 197,840 | 1.84B |
| 186 | ELVN | Enliven Therapeutics, Inc. | 4.25B | 0.14% | 106,118 | - |
| 187 | TLX | Telix Pharmaceuticals Limited | 4.17B | 2.76% | 36,787 | 803.79M |
| 188 | HAE | Haemonetics Corporation | 4.16B | 0.11% | 117,622 | 1.35B |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.10B | -0.66% | 50,535 | 825.34M |
| 190 | DNLI | Denali Therapeutics Inc. | 4.03B | -0.12% | 272,075 | 3.60M |
| 191 | LEGN | Legend Biotech Corporation | 4.00B | 0.24% | 404,980 | 1.27B |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 3.97B | -1.47% | 200,453 | 308.08M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.89B | -2.09% | 621,758 | - |
| 194 | GPCR | Structure Therapeutics Inc. | 3.84B | -0.04% | 145,773 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.70B | 0.29% | 169,914 | 117.00M |
| 196 | OPCH | Option Care Health, Inc. | 3.61B | 0.96% | 198,476 | 5.69B |
| 197 | OGN | Organon & Co. | 3.60B | 0.33% | 814,033 | 6.13B |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.57B | 0.19% | 117,559 | 234.13M |
| 199 | VCYT | Veracyte, Inc. | 3.55B | -1.04% | 171,235 | 561.90M |
| 200 | NHC | National HealthCare Corporation | 3.48B | 0.18% | 37,078 | 1.56B |
| 201 | CLDX | Celldex Therapeutics, Inc. | 3.46B | -1.85% | 128,169 | 158.00K |
| 202 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.11% | 315,071 | 7.12M |
| 203 | ABCL | AbCellera Biologics Inc. | 3.29B | 3.72% | 9,788,165 | 66.17M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -0.84% | 459,684 | 463.98M |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.25B | 5.12% | 163,971 | 1.19M |
| 206 | ALMS | Alumis Inc. | 3.23B | -0.90% | 87,634 | 8.40M |
| 207 | MBX | MBX Biosciences, Inc. | 3.22B | -0.01% | 64,445 | - |
| 208 | WRBY | Warby Parker Inc. | 3.18B | 1.62% | 325,855 | 911.61M |
| 209 | QURE | uniQure N.V. | 3.16B | 0.82% | 242,437 | 18.67M |
| 210 | BKD | Brookdale Senior Living Inc. | 3.11B | 0.35% | 650,063 | 2.93B |
| 211 | IMNM | Immunome, Inc. | 3.09B | -2.72% | 229,460 | 4.02M |
| 212 | IRON | Disc Medicine, Inc. | 3.07B | -0.66% | 56,502 | - |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | -0.39% | 135,965 | 606.33M |
| 214 | TMDX | TransMedics Group, Inc. | 3.04B | 0.85% | 119,896 | 668.47M |
| 215 | GRAL | GRAIL, Inc. | 3.04B | -1.36% | 129,924 | 165.26M |
| 216 | IOVA | Iovance Biotherapeutics, Inc. | 2.96B | -2.97% | 4,965,429 | 324.97M |
| 217 | ZLAB | Zai Lab Limited | 2.91B | 1.77% | 477,694 | 449.61M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.90B | -1.64% | 83,794 | 3.37B |
| 219 | ALHC | Alignment Healthcare, Inc. | 2.83B | 0.81% | 383,448 | 4.58B |
| 220 | NRIX | Nurix Therapeutics, Inc. | 2.81B | 1.50% | 294,073 | 36.77M |
| 221 | PRVA | Privia Health Group, Inc. | 2.79B | 1.30% | 184,208 | 2.36B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.77B | -0.31% | 117,914 | 830.44M |
| 223 | KOD | Kodiak Sciences Inc. | 2.68B | -0.94% | 76,353 | - |
| 224 | ATAI | AtaiBeckley Inc. | 2.68B | 0.07% | 912,751 | 4.47M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.66B | -0.30% | 517,481 | 156.04M |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.63B | -0.48% | 129,397 | 717.00M |
| 227 | AXGN | Axogen, Inc. | 2.62B | -1.91% | 160,410 | 251.17M |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.60B | 2.93% | 1,075,031 | - |
| 229 | NKTR | Nektar Therapeutics | 2.60B | 1.05% | 157,117 | 55.63M |
| 230 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.59B | -0.60% | 167,045 | -665.00K |
| 231 | HTFL | HeartFlow, Inc. | 2.58B | 0.07% | 281,397 | 191.42M |
| 232 | COAG | Hemab Therapeutics Holdings, Inc. | 2.56B | 2.43% | 37,316 | - |
| 233 | RGC | Regencell Bioscience Holdings Limited | 2.55B | 1.58% | 87,981 | - |
| 234 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.54B | -6.19% | 1,851,001 | 940.61M |
| 235 | VRDN | Viridian Therapeutics, Inc. | 2.53B | -2.32% | 262,135 | 71.13M |
| 236 | NEOG | Neogen Corporation | 2.52B | 0.70% | 360,911 | 870.40M |
| 237 | UFPT | UFP Technologies, Inc. | 2.51B | 0.69% | 44,301 | 631.64M |
| 238 | KLRA | Kailera Therapeutics, Inc. | 2.48B | 2.80% | 73,144 | - |
| 239 | BFLY | Butterfly Network, Inc. | 2.46B | -2.17% | 1,917,996 | 112.14M |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.45B | -1.19% | 109,205 | 1.10B |
| 241 | PHVS | Pharvaris N.V. | 2.45B | -4.42% | 353,393 | - |
| 242 | GRDN | Guardian Pharmacy Services, Inc. | 2.45B | 0.05% | 67,348 | 1.46B |
| 243 | CDNA | CareDx, Inc. | 2.43B | -0.78% | 112,650 | 458.09M |
| 244 | WGS | GeneDx Holdings Corp. | 2.42B | -1.61% | 82,343 | 454.43M |
| 245 | URGN | UroGen Pharma Ltd. | 2.40B | 0.41% | 193,703 | 188.73M |
| 246 | CLOV | Clover Health Investments, Corp. | 2.40B | -0.44% | 1,384,089 | 2.48B |
| 247 | SLS | SELLAS Life Sciences Group, Inc. | 2.40B | 0.76% | 1,771,466 | - |
| 248 | PGEN | Precigen, Inc. | 2.37B | -3.36% | 1,131,781 | 85.72M |
| 249 | ALMR | Alamar Biosciences, Inc. | 2.36B | 2.66% | 122,468 | 100.42M |
| 250 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | -1.35% | 262,867 | - |
| 251 | AVAH | Aveanna Healthcare Holdings Inc. | 2.34B | 18.78% | 2,959,904 | 2.60B |
| 252 | BHC | Bausch Health Companies Inc. | 2.34B | 0.64% | 622,107 | 10.85B |
| 253 | RAPP | Rapport Therapeutics, Inc. | 2.31B | 0.98% | 35,071 | 20.00M |
| 254 | ESTA | Establishment Labs Holdings Inc. | 2.30B | 2.29% | 127,384 | 245.82M |
| 255 | XRAY | DENTSPLY SIRONA Inc. | 2.28B | 0.44% | 614,152 | 3.64B |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 2.27B | -1.86% | 126,688 | 959.90M |
| 257 | VCEL | Vericel Corporation | 2.26B | -1.16% | 106,498 | 306.30M |
| 258 | PVLA | Palvella Therapeutics, Inc. | 2.25B | 0.67% | 88,748 | - |
| 259 | OCUL | Ocular Therapeutix, Inc. | 2.24B | -0.39% | 622,961 | 52.06M |
| 260 | ATRC | AtriCure, Inc. | 2.23B | 0.81% | 57,277 | 569.62M |
| 261 | NUVB | Nuvation Bio Inc. | 2.23B | -1.09% | 687,446 | 169.90M |
| 262 | MESO | Mesoblast Limited | 2.19B | -1.97% | 48,125 | 65.38M |
| 263 | BHVN | Biohaven Ltd. | 2.18B | 0.42% | 179,268 | - |
| 264 | SEPN | Septerna, Inc. | 2.17B | -3.51% | 193,548 | 98.88M |
| 265 | ADUS | Addus HomeCare Corporation | 2.16B | 0.08% | 26,073 | 1.48B |
| 266 | VERA | Vera Therapeutics, Inc. | 2.13B | -1.47% | 355,046 | - |
| 267 | HCM | HUTCHMED (China) Limited | 2.12B | -1.06% | 19,200 | 549.12M |
| 268 | STOK | Stoke Therapeutics, Inc. | 2.12B | -0.55% | 97,082 | 27.59M |
| 269 | NEO | NeoGenomics, Inc. | 2.11B | - | 161,113 | 766.30M |
| 270 | ADMA | ADMA Biologics, Inc. | 2.10B | -3.99% | 565,295 | 512.28M |
| 271 | MD | Pediatrix Medical Group, Inc. | 2.08B | -1.02% | 166,659 | 1.95B |
| 272 | NVCR | NovoCure Limited | 2.04B | -0.45% | 95,111 | 699.19M |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | -0.64% | 124,724 | 98.34M |
| 274 | NBTX | Nanobiotix S.A. | 2.02B | -3.58% | 48,629 | 38.27M |
| 275 | KARD | Kardigan, Inc. | 2.02B | -0.83% | 56,555 | - |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 2.01B | -3.75% | 459,279 | 5.49M |
| 277 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -2.52% | 419,455 | 311.51M |
| 278 | PGNY | Progyny, Inc. | 2.00B | 2.48% | 167,313 | 1.31B |
| 279 | SGRY | Surgery Partners, Inc. | 1.99B | 0.16% | 380,003 | 3.37B |
| 280 | GHRS | GH Research PLC | 1.98B | -4.63% | 162,950 | - |
| 281 | GENB | Generate Biomedicines, Inc. | 1.97B | 1.79% | 165,076 | 26.48M |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | 0.87% | 556,451 | 1.97B |
| 283 | ASTH | Astrana Health, Inc. | 1.90B | 3.93% | 62,351 | 3.84B |
| 284 | LMAT | LeMaitre Vascular, Inc. | 1.89B | 0.79% | 65,897 | 262.43M |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.88B | -1.65% | 40,473 | - |
| 286 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.05% | 501,948 | - |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.88B | 1.51% | 63,147 | 481.07M |
| 288 | CMPS | COMPASS Pathways plc | 1.88B | -4.71% | 934,494 | - |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 0.50% | 111,812 | 1.13B |
| 290 | ZBIO | Zenas BioPharma, Inc. | 1.83B | -7.29% | 270,300 | 1.00M |
| 291 | TRLV | Trulieve Cannabis Corp. | 1.82B | 3.68% | 375,299 | 1.14B |
| 292 | ZYME | Zymeworks Inc. | 1.80B | 1.89% | 197,639 | 37.13M |
| 293 | IMCR | Immunocore Holdings plc | 1.77B | -1.18% | 105,190 | 430.78M |
| 294 | PRGO | Perrigo Company plc | 1.76B | - | 370,432 | 4.14B |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -0.30% | 3,119,842 | 54.86M |
| 296 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -1.21% | 338,577 | 252.25M |
| 297 | AAPG | Ascentage Pharma Group International | 1.74B | 1.08% | 1,271 | 82.08M |
| 298 | FTRE | Fortrea Holdings Inc. | 1.74B | -0.22% | 316,382 | 2.68B |
| 299 | BLFS | BioLife Solutions, Inc. | 1.71B | -0.11% | 82,996 | 106.69M |
| 300 | OMCL | Omnicell, Inc. | 1.71B | 0.75% | 113,765 | 1.25B |
| 301 | ANAB | AnaptysBio, Inc. | 1.70B | 0.80% | 73,940 | 232.39M |
| 302 | XNCR | Xencor, Inc. | 1.68B | -2.24% | 142,402 | 104.97M |
| 303 | AVLN | Avalyn Pharma Inc. | 1.67B | 1.02% | 119,267 | - |
| 304 | INSP | Inspire Medical Systems, Inc. | 1.67B | -0.79% | 133,438 | 898.74M |
| 305 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -1.49% | 827,091 | 59.51M |
| 306 | TRAX | First Tracks Biotherapeutics, Inc. | 1.64B | -0.75% | 149,334 | - |
| 307 | KMTS | Kestra Medical Technologies, Ltd. | 1.64B | -0.32% | 51,053 | 95.13M |
| 308 | BRVE | Braveheart Bio, Inc. | 1.62B | -3.16% | 142,737 | - |
| 309 | TNDM | Tandem Diabetes Care, Inc. | 1.62B | -0.64% | 167,834 | 1.04B |
| 310 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -0.32% | 44,013 | 978.38M |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.60B | -2.03% | 118,404 | - |
| 312 | ABSI | Absci Corporation | 1.58B | -2.89% | 765,581 | 1.56M |
| 313 | XERS | Xeris Biopharma Holdings, Inc. | 1.56B | 0.59% | 457,976 | 335.41M |
| 314 | ARDT | Ardent Health, Inc. | 1.56B | -0.63% | 23,340 | 6.41B |
| 315 | VIR | Vir Biotechnology, Inc. | 1.54B | 1.67% | 363,972 | 303.23M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.53B | 0.29% | 60,352 | 20.00M |
| 317 | PSNL | Personalis, Inc. | 1.52B | 0.21% | 388,499 | 69.67M |
| 318 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.52B | 1.12% | 204,591 | 208.78M |
| 319 | HROW | Harrow, Inc. | 1.51B | 2.44% | 81,091 | 275.59M |
| 320 | INVA | Innoviva, Inc. | 1.51B | 0.29% | 52,613 | 440.00M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.53% | 84,257 | - |
| 322 | CNMD | CONMED Corporation | 1.49B | 0.22% | 36,837 | 1.37B |
| 323 | OMDA | Omada Health, Inc. | 1.48B | 1.72% | 325,858 | 309.76M |
| 324 | ATEC | Alphatec Holdings, Inc. | 1.48B | -0.21% | 284,273 | 815.05M |
| 325 | AGL | agilon health, inc. | 1.48B | 2.28% | 61,563 | 5.92B |
| 326 | JBIO | Jade Biosciences, Inc. | 1.48B | 0.26% | 80,169 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.48B | -4.64% | 183,665 | - |
| 328 | AZTA | Azenta, Inc. | 1.48B | 0.48% | 87,325 | 613.81M |
| 329 | INBX | Inhibrx Biosciences, Inc. | 1.46B | 1.16% | 66,602 | 1.30M |
| 330 | REPL | Replimune Group, Inc. | 1.46B | 1.97% | 1,076,613 | - |
| 331 | HCSG | Healthcare Services Group, Inc. | 1.46B | 1.97% | 152,082 | 1.86B |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.46B | -0.61% | 112,149 | - |
| 333 | IART | Integra LifeSciences Holdings Corporation | 1.44B | 6.36% | 251,439 | 1.65B |
| 334 | INNV | InnovAge Holding Corp. | 1.43B | 1.20% | 17,914 | 949.17M |
| 335 | MLTX | MoonLake Immunotherapeutics | 1.42B | -3.48% | 490,056 | - |
| 336 | ENOV | Enovis Corporation | 1.41B | -1.05% | 125,495 | 2.30B |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | -1.45% | 223,416 | - |
| 338 | ALVO | Alvotech | 1.40B | -2.37% | 235,152 | 562.04M |
| 339 | PAHC | Phibro Animal Health Corporation | 1.39B | 1.15% | 29,147 | 1.50B |
| 340 | SDGR | Schrรถdinger, Inc. | 1.38B | -0.70% | 229,055 | 259.04M |
| 341 | AORT | Artivion, Inc. | 1.38B | -0.91% | 54,046 | 471.47M |
| 342 | GLUE | Monte Rosa Therapeutics, Inc. | 1.38B | 1.50% | 159,302 | 28.73M |
| 343 | SVRA | Savara Inc. | 1.38B | -4.74% | 461,028 | - |
| 344 | VOR | Vor Biopharma Inc. | 1.37B | 3.67% | 283,979 | - |
| 345 | PNTG | The Pennant Group, Inc. | 1.36B | 1.35% | 43,077 | 1.10B |
| 346 | DRTS | Alpha Tau Medical Ltd. | 1.35B | 5.73% | 403,076 | - |
| 347 | NVAX | Novavax, Inc. | 1.34B | 2.32% | 1,142,938 | 413.80M |
| 348 | AKTS | Aktis Oncology, Inc. | 1.33B | 0.36% | 46,143 | 8.28M |
| 349 | IMTX | Immatics N.V. | 1.32B | -0.31% | 60,220 | 43.00M |
| 350 | FRNM | Freenome, Inc. | 1.32B | 0.91% | 260,056 | 34.24M |
| 351 | AMN | AMN Healthcare Services, Inc. | 1.31B | 4.56% | 98,420 | 3.43B |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 2.77% | 35,683 | - |
| 353 | MGTX | MeiraGTx Holdings plc | 1.28B | 6.52% | 219,384 | 397.50M |
| 354 | CGEM | Cullinan Therapeutics, Inc. | 1.28B | 1.33% | 621,746 | - |
| 355 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 0.60% | 174,042 | - |
| 356 | AHG | Akso Health Group | 1.27B | 0.71% | 222 | 13.83M |
| 357 | TDOC | Teladoc Health, Inc. | 1.26B | 3.58% | 1,084,843 | 2.49B |
| 358 | PRCT | PROCEPT BioRobotics Corporation | 1.26B | 3.44% | 497,571 | 337.34M |
| 359 | LTGO | Latigo Biotherapeutics, Inc. | 1.26B | 2.71% | 29,594 | - |
| 360 | ANRO | Alto Neuroscience, Inc. | 1.26B | 10.69% | 155,971 | - |
| 361 | NUTX | Nutex Health Inc. | 1.26B | 6.28% | 48,315 | 846.72M |
| 362 | STAA | STAAR Surgical Company | 1.25B | -2.28% | 711,532 | 339.59M |
| 363 | GDRX | GoodRx Holdings, Inc. | 1.24B | 1.11% | 251,780 | 785.23M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 1.24B | 1.12% | 56,000 | 804.27M |
| 365 | MNKD | MannKind Corporation | 1.21B | -2.60% | 1,311,629 | 393.63M |
| 366 | CERT | Certara, Inc. | 1.21B | -1.37% | 1,772,626 | 421.75M |
| 367 | OMER | Omeros Corporation | 1.18B | 19.26% | 7,192,999 | 38.42M |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | 4.26% | 400,227 | 1.04B |
| 369 | CRON | Cronos Group Inc. | 1.17B | 1.42% | 802,905 | 179.09M |
| 370 | ETON | Eton Pharmaceuticals, Inc. | 1.17B | 2.93% | 78,402 | 86.93M |
| 371 | EYPT | EyePoint, Inc. | 1.16B | -0.22% | 247,890 | 2.79M |
| 372 | BVS | Bioventus Inc. | 1.16B | -0.83% | 120,414 | 581.85M |
| 373 | IRMD | IRADIMED CORPORATION | 1.13B | 0.80% | 23,173 | 86.34M |
| 374 | IVA | Inventiva S.A. | 1.12B | - | 219,643 | 7.94M |
| 375 | APMD | Apnimed, Inc. | 1.12B | 5.39% | 166,895 | 120.15M |
| 376 | SANA | Sana Biotechnology, Inc. | 1.10B | -2.12% | 563,921 | - |
| 377 | WVE | Wave Life Sciences Ltd. | 1.06B | 3.05% | 1,323,275 | 65.37M |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | 1.06% | 831,162 | 41.47M |
| 379 | GMRS | GMR Solutions Inc. | 1.05B | 4.98% | 1,709,304 | 5.83B |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.05B | -0.26% | 57,188 | 59.00K |
| 381 | OPK | OPKO Health, Inc. | 1.04B | 0.72% | 584,676 | 587.90M |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | -0.56% | 21,711 | 99.00K |
| 383 | QDEL | QuidelOrtho Corporation | 1.01B | -0.40% | 230,052 | 2.67B |
| 384 | GERN | Geron Corporation | 1.01B | 0.32% | 2,001,874 | 204.56M |
| 385 | ANNX | Annexon, Inc. | 998.13M | -1.22% | 708,294 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 996.53M | -2.22% | 161,645 | 24.00M |
| 387 | SLDB | Solid Biosciences Inc. | 977.89M | 0.61% | 131,929 | - |
| 388 | ARDX | Ardelyx, Inc. | 969.34M | -2.02% | 1,096,276 | 450.89M |
| 389 | CSTL | Castle Biosciences, Inc. | 965.98M | 0.60% | 79,281 | 357.28M |
| 390 | PCRX | Pacira BioSciences, Inc. | 950.31M | 0.59% | 65,755 | 746.16M |
| 391 | OBX | Obsidian Therapeutics, Inc. | 931.52M | -23.21% | 66,202 | - |
| 392 | KURA | Kura Oncology, Inc. | 929.47M | 5.33% | 2,447,138 | 77.23M |
| 393 | COLL | Collegium Pharmaceutical, Inc. | 926.86M | 10.78% | 373,392 | 808.21M |
| 394 | GLAS | Glass House Brands Inc. | 926.42M | 0.39% | 90,651 | 177.68M |
| 395 | OLMA | Olema Pharmaceuticals, Inc. | 914.35M | 0.10% | 358,299 | - |
| 396 | ABUS | Arbutus Biopharma Corporation | 912.08M | 0.44% | 254,496 | 181.72M |
| 397 | DSGN | Design Therapeutics, Inc. | 903.68M | -1.50% | 29,312 | - |
| 398 | CBLL | CeriBell, Inc. | 885.96M | 0.76% | 155,783 | 101.96M |
| 399 | TBPH | Theravance Biopharma, Inc. | 878.21M | -0.03% | 72,668 | 104.31M |
| 400 | AVR | Anteris Technologies Global Corp. | 877.10M | 1.47% | 81,808 | 2.24M |
| 401 | INMD | InMode Ltd. | 870.83M | -0.53% | 90,743 | 374.63M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 869.95M | 1.20% | 241,978 | 8.22M |
| 403 | TALK | Talkspace, Inc. | 869.75M | 0.10% | 166,971 | 245.73M |
| 404 | CLYM | Climb Bio, Inc. | 856.37M | 3.61% | 497,946 | - |
| 405 | SIBN | SI-BONE, Inc. | 854.91M | 0.39% | 47,252 | 213.60M |
| 406 | SGP | SpyGlass Pharma, Inc. | 853.09M | 0.93% | 23,318 | - |
| 407 | AMPH | Amphastar Pharmaceuticals, Inc. | 848.21M | -0.20% | 69,673 | 730.02M |
| 408 | HSTM | HealthStream, Inc. | 835.68M | 0.78% | 39,046 | 321.12M |
| 409 | DBVT | DBV Technologies S.A. | 833.37M | -0.92% | 96,738 | 5.04M |
| 410 | AURA | Aura Biosciences, Inc. | 827.56M | 2.97% | 490,578 | - |
| 411 | CADL | Candel Therapeutics, Inc. | 821.36M | 4.96% | 772,093 | - |
| 412 | PHAR | Pharming Group N.V. | 820.19M | 0.59% | 14,855 | 366.48M |
| 413 | IMMX | Immix Biopharma, Inc. | 818.41M | 0.62% | 220,562 | - |
| 414 | BBNX | Beta Bionics, Inc. | 818.36M | 4.96% | 479,688 | 119.01M |
| 415 | ATTO | Attovia Therapeutics, Inc. | 817.55M | 5.20% | 148,188 | 1.35M |
| 416 | OCS | Oculis Holding AG | 805.60M | 1.24% | 50,434 | 1.45M |
| 417 | EVO | Evotec SE | 789.86M | -7.53% | 13,085 | 819.47M |
| 418 | DRUG | Bright Minds Biosciences Inc. | 787.36M | -0.20% | 43,069 | - |
| 419 | VREX | Varex Imaging Corporation | 780.16M | 0.33% | 370,266 | 865.00M |
| 420 | AHCO | AdaptHealth Corp. | 776.44M | 0.87% | 509,411 | 3.36B |
| 421 | SSII | SS Innovations International, Inc. | 768.51M | 4.07% | 16,825 | 48.47M |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 765.02M | 1.38% | 40,338 | - |
| 423 | PHR | Phreesia, Inc. | 764.92M | 0.94% | 66,661 | 495.59M |
| 424 | FTH | Faeth Therapeutics, Inc. | 761.00M | 0.24% | 69,417 | - |
| 425 | RIGL | Rigel Pharmaceuticals, Inc. | 760.46M | -2.77% | 55,859 | 276.79M |
| 426 | MNPR | Monopar Therapeutics Inc. | 753.44M | -2.31% | 76,780 | - |
| 427 | STTK | Shattuck Labs, Inc. | 751.72M | - | 197,868 | 1.00M |
| 428 | NGNE | Neurogene Inc. | 740.42M | 0.05% | 64,457 | 925.00K |
| 429 | CTMX | CytomX Therapeutics, Inc. | 733.23M | -3.58% | 413,614 | 18.30M |
| 430 | HELP | Cybin Inc. | 732.03M | 2.79% | 840,933 | - |
| 431 | ACHV | Achieve Life Sciences, Inc. | 724.43M | 5.23% | 1,172,912 | - |
| 432 | PHAT | Phathom Pharmaceuticals, Inc. | 722.81M | -0.76% | 324,967 | 239.66M |
| 433 | RGNX | REGENXBIO Inc. | 712.94M | -1.01% | 194,403 | 174.48M |
| 434 | ALLO | Allogene Therapeutics, Inc. | 711.71M | -0.48% | 1,975,532 | 4.64M |
| 435 | CBIO | Crescent Biopharma, Inc. | 705.79M | 0.37% | 21,647 | 11.88M |
| 436 | GYRE | Gyre Therapeutics, Inc. | 704.06M | -0.30% | 18,314 | 109.82M |
| 437 | TECX | Tectonic Therapeutic, Inc. | 697.72M | -3.10% | 73,495 | - |
| 438 | AGMB | AgomAb Therapeutics NV | 689.47M | -0.78% | 17,192 | - |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 678.31M | -4.98% | 607,080 | 389.32M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 668.66M | -1.57% | 174,075 | 136.07M |
| 441 | SLN | Silence Therapeutics plc | 662.22M | 3.24% | 1,196,576 | 615.00K |
| 442 | ANGO | AngioDynamics, Inc. | 654.29M | 0.51% | 163,721 | 320.17M |
| 443 | CRMD | CorMedix Inc. | 651.15M | 16.90% | 2,556,561 | 462.25M |
| 444 | KIDS | OrthoPediatrics Corp. | 648.31M | -0.12% | 63,967 | 252.72M |
| 445 | CTEV | Claritev Corporation | 643.16M | 7.45% | 43,021 | 994.67M |
| 446 | NVCT | Nuvectis Pharma, Inc. | 641.20M | 0.72% | 30,936 | - |
| 447 | SOPH | SOPHiA GENETICS SA | 640.59M | -0.59% | 180,117 | 86.17M |
| 448 | STLN | Starling Oncology, Inc. | 637.99M | -0.95% | 301,790 | 587.24M |
| 449 | TLRY | Tilray Brands, Inc. | 637.39M | 0.43% | 1,169,189 | 915.45M |
| 450 | BWAY | BrainsWay Ltd. | 631.83M | 2.53% | 115,859 | 56.22M |
| 451 | CTKB | Cytek Biosciences, Inc. | 630.42M | 1.46% | 154,023 | 206.71M |
| 452 | VSTM | Verastem, Inc. | 618.10M | -1.80% | 505,710 | 87.53M |
| 453 | MDXG | MiMedx Group, Inc. | 615.11M | -1.40% | 335,337 | 355.17M |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 596.99M | -3.79% | 86,090 | 88.24M |
| 455 | AUTL | Autolus Therapeutics plc | 596.16M | 5.66% | 1,015,999 | 117.39M |
| 456 | CTNM | Contineum Therapeutics, Inc. | 594.41M | 5.47% | 150,827 | - |
| 457 | SPRY | ARS Pharmaceuticals, Inc. | 591.85M | -1.49% | 465,368 | 98.99M |
| 458 | ARVN | Arvinas, Inc. | 590.44M | 1.80% | 167,462 | 316.70M |
| 459 | DCTH | Delcath Systems, Inc. | 588.49M | -0.88% | 83,056 | 95.42M |
| 460 | SGMT | Sagimet Biosciences Inc. | 577.45M | -1.06% | 335,843 | - |
| 461 | PRLD | Prelude Therapeutics Incorporated | 574.71M | -2.62% | 278,080 | 22.42M |
| 462 | ASMB | Assembly Biosciences, Inc. | 573.25M | 10.04% | 346,709 | 71.10M |
| 463 | EIKN | Eikon Therapeutics, Inc. | 569.27M | 0.91% | 119,906 | - |
| 464 | PRME | Prime Medicine, Inc. | 563.96M | -0.94% | 656,481 | 4.07M |
| 465 | ALT | Altimmune, Inc. | 562.16M | -1.37% | 1,492,520 | 31.00K |
| 466 | CERS | Cerus Corporation | 560.24M | 2.58% | 723,739 | 221.55M |
| 467 | ARTV | Artiva Biotherapeutics, Inc. | 554.90M | -1.56% | 99,070 | 251.00K |
| 468 | ZURA | Zura Bio Limited | 547.80M | -1.10% | 286,183 | - |
| 469 | EOLS | Evolus, Inc. | 546.24M | 1.85% | 225,324 | 316.49M |
| 470 | TCMD | Tactile Systems Technology, Inc. | 545.92M | -1.67% | 105,853 | 350.31M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 544.72M | 2.60% | 1,275,573 | 54.09M |
| 472 | VALN | Valneva SE | 538.47M | -0.72% | 13,128 | 163.30M |
| 473 | MPLT | MapLight Therapeutics, Inc. | 536.89M | 4.04% | 128,916 | - |
| 474 | SRTA | Strata Critical Medical, Inc. | 525.05M | -1.58% | 197,138 | 255.98M |
| 475 | EVMN | Evommune, Inc. | 521.88M | 1.84% | 150,553 | 10.00M |
| 476 | OABI | OmniAb, Inc. | 520.50M | 4.68% | 394,708 | 38.46M |
| 477 | FLGT | Fulgent Genetics, Inc. | 518.11M | 0.64% | 22,604 | 323.93M |
| 478 | ANL | Adlai Nortye Ltd. | 516.00M | -1.45% | 13,103 | 5.00M |
| 479 | NPCE | NeuroPace, Inc. | 511.09M | 2.27% | 30,929 | 106.99M |
| 480 | OVID | Ovid Therapeutics Inc. | 507.66M | 3.82% | 590,424 | 1.58M |
| 481 | BLSM | BlossomHill Therapeutics, Inc. | 505.62M | 1.60% | 83,525 | - |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 483 | RLMD | Relmada Therapeutics, Inc. | 501.35M | -0.42% | 273,156 | - |
| 484 | RZLT | Rezolute, Inc. | 496.22M | 1.06% | 219,658 | - |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 495.48M | 1.24% | 229,675 | - |
| 486 | EVH | Evolent Health, Inc. | 494.07M | 4.80% | 722,949 | 2.10B |
| 487 | ENTX | Entera Bio Ltd. | 493.45M | 1.79% | 73,400 | 42.00K |
| 488 | DNA | Ginkgo Bioworks Holdings, Inc. | 489.56M | 0.83% | 364,369 | 132.42M |
| 489 | BIOA | BioAge Labs, Inc. | 488.80M | 1.62% | 109,365 | 10.36M |
| 490 | CCCC | C4 Therapeutics, Inc. | 481.03M | 0.26% | 1,186,122 | 35.04M |
| 491 | PRTA | Prothena Corporation plc | 477.18M | 0.38% | 53,498 | 54.53M |
| 492 | OCGN | Ocugen, Inc. | 466.28M | -1.79% | 1,667,629 | 4.58M |
| 493 | NRC | NRC Health | 465.84M | 2.18% | 24,188 | 140.00M |
| 494 | CLPT | ClearPoint Neuro, Inc. | 465.04M | 0.43% | 51,068 | 42.28M |
| 495 | QTTB | Q32 Bio Inc. | 463.81M | 1.37% | 59,319 | 53.74M |
| 496 | PBYI | Puma Biotechnology, Inc. | 460.65M | 0.27% | 25,050 | 231.24M |
| 497 | SGHT | Sight Sciences, Inc. | 458.33M | 0.48% | 100,600 | 83.38M |
| 498 | CABA | Cabaletta Bio, Inc. | 448.40M | -3.51% | 1,287,560 | - |
| 499 | LRMR | Larimar Therapeutics, Inc. | 444.67M | -2.52% | 445,282 | - |
| 500 | SLBT | SL Science Holding Limited | 444.47M | 3.00% | 6,455 | 3.27M |